Tetrahydrofuran → N-[7-(Fluoromethyl)-2-[[[(4-fluoro-3-methylphenyl)methyl]amino]carbonyl]-6,7,8,9-tetrahydro-3-hydroxy-4-oxo-7,10-ethanopyrimido[1,2-a]azepin-10(4H)-yl]-N,N',N'-trimethyl-ethanediamide

HRID 75730Notes

Reaction equation

HRID 75730 reaction equation
[F:1][C:2]1[CH:7]=[CH:6][C:5]([CH2:8][NH:9][C:10]([C:12]2[N:13]=[C:14]3[C:20]4([N:23]([CH3:31])[C:24](=[O:30])[C:25]([N:27]([CH3:29])[CH3:28])=[O:26])[CH2:21][CH2:22][C:17]([CH2:32]OS(C5C=CC(C)=CC=5)(=O)=O)([CH2:18][CH2:19]4)[CH2:16][N:15]3[C:44](=[O:47])[C:45]=2[OH:46])=[O:11])=[CH:4][C:3]=1[CH3:48].CCCC[N+](CCCC)(CCCC)CCCC.[F-:66].C1COCC1>>[F:66][CH2:32][C:17]12[CH2:22][CH2:21][C:20]([N:23]([CH3:31])[C:24](=[O:30])[C:25]([N:27]([CH3:29])[CH3:28])=[O:26])([C:14]3[N:15]([C:44](=[O:47])[C:45]([OH:46])=[C:12]([C:10]([NH:9][CH2:8][C:5]4[CH:6]=[CH:7][C:2]([F:1])=[C:3]([CH3:48])[CH:4]=4)=[O:11])[N:13]=3)[CH2:16]1)[CH2:19][CH2:18]2

Participants

4

Procedure

A mixture of N-[2-[[[(4-fluoro-3-methylphenyl)methyl]amino]carbonyl]-6,7,8,9-tetrahydro-3-hydroxy-7-[[[(4-methylphenyl)sulfonyl]oxy]methyl]-4-oxo-7,10-ethanopyrimido[1,2-a]azepin-10(4H)-yl]-N,N′,N′-trimethyl-ethanediamide, Intermediate 28, (50 mg, 0.073 mmol) was treated with TBAF, 1M in THF (1.5 mL, 1.500 mmol) and 4 Å molecular sieves. The mixture was then stirred for 30 min at room temp and heated at 80° C. for 18 h. After cooling the reaction mixture was concentrated and purified by preparative HPLC to afford the title compound (14 mg, 0.025 mmol, 34.2% yield) as an off-white solid. 1H NMR (500 MHz, CDCl3) δ: 12.18 (1H, br. s.), 9.60 (1H, br. s.), 7.17-7.26 (2H, m), 6.94 (1H, t, J=8.85 Hz), 4.75 (1H, d, J=14.95 Hz), 4.56-4.65 (1H, m), 4.39-4.50 (1H, m), 4.28 (1H, d, J=2.75 Hz), 4.19 (1H, d, J=2.75 Hz), 3.42-3.57 (2H, m), 3.05 (3H, s), 3.03 (3H, s), 3.01 (3H, s), 2.27 (3H, s), 2.07-2.18 (3H, m), 1.80-1.88 (1H, m), 1.70-1.78 (2H, m), 1.42-1.52 (1H, m). LCMS (M+H)=532.4.

Workup

  1. temperatureheated at 80° C. for 18 h
  2. temperatureAfter cooling the reaction mixture
  3. concentrationwas concentrated
  4. custompurified by preparative HPLC

Sources & evidence

ORD record
ord-78f759a14cb64838907fd26c47e66711
Source dataset
uspto-grants-2014_09
Patent number
US08835411B2

Reaction notes

Loading…